JO3600B1 - لقاحات مؤتلفة ل fmdv و استخداماتها - Google Patents

لقاحات مؤتلفة ل fmdv و استخداماتها

Info

Publication number
JO3600B1
JO3600B1 JOP/2015/0240A JOP20150240A JO3600B1 JO 3600 B1 JO3600 B1 JO 3600B1 JO P20150240 A JOP20150240 A JO P20150240A JO 3600 B1 JO3600 B1 JO 3600B1
Authority
JO
Jordan
Prior art keywords
fmdv
vaccine
vaccines
recombinant fmdv
fmdv vaccines
Prior art date
Application number
JOP/2015/0240A
Other languages
English (en)
Inventor
Audonnet Jean-Christophe
Widner Justin
Hannas-Djebbara Zahia
Mebatsion Teshome
Chiang Yu-Wei
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Application granted granted Critical
Publication of JO3600B1 publication Critical patent/JO3600B1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

يشتمل الاختراع الحالي على لقاحات أو تركيبات FMDV. قد يكون اللقاح أو التركيبة لقاحًا أو تركيبة تحتوي على مستضدات الحمى القلاعية. يشتمل الاختراع أيضًا على نواقل مؤتلفة ترميز وتعبر عن مستضدات FMDV أو الحلقية أو المستضدات المناعية التي يمكن استخدامها لحماية الحيوانات ، وخاصة الأفران أو الأبقار أو الأغنام أو الخنازير ضد فيروس الحمى القلاعية.
JOP/2015/0240A 2014-09-23 2015-09-28 لقاحات مؤتلفة ل fmdv و استخداماتها JO3600B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462054073P 2014-09-23 2014-09-23

Publications (1)

Publication Number Publication Date
JO3600B1 true JO3600B1 (ar) 2020-07-05

Family

ID=54256845

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2015/0240A JO3600B1 (ar) 2014-09-23 2015-09-28 لقاحات مؤتلفة ل fmdv و استخداماتها

Country Status (17)

Country Link
US (1) US10010605B2 (ar)
EP (1) EP3197486A1 (ar)
JP (1) JP6931327B2 (ar)
KR (1) KR102526219B1 (ar)
CN (1) CN107073100B (ar)
AP (1) AP2017009834A0 (ar)
AR (1) AR102006A1 (ar)
AU (2) AU2015320673B2 (ar)
CA (1) CA2962225A1 (ar)
JO (1) JO3600B1 (ar)
MA (1) MA40151B2 (ar)
MX (1) MX388708B (ar)
PY (1) PY1548374A (ar)
RU (1) RU2745373C2 (ar)
TW (1) TWI733653B (ar)
WO (1) WO2016049209A1 (ar)
ZA (1) ZA201701851B (ar)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10391163B2 (en) 2015-09-10 2019-08-27 Academia Sinica Bird flu vaccine combination comprising virus-like particles and novel adjuvants
CA3006078A1 (en) 2015-11-23 2017-06-01 Merial, Inc. Fmdv and e2 fusion proteins and uses thereof
TWI760322B (zh) 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途
US10172933B2 (en) * 2016-10-31 2019-01-08 The United States Of America, As Represented By The Secretary Of Agriculture Mosaic vaccines for serotype a foot-and-mouth disease virus
US11179457B2 (en) * 2017-07-12 2021-11-23 Boehringer Ingelheim Animal Health USA Inc. Senecavirus a immunogenic compositions and methods thereof
CN108103034B (zh) * 2017-12-15 2022-06-24 云南农业大学动物医学院 同时表达A型、O型和Asia-1型口蹄疫病毒VP1基因重组腺病毒、构建方法及应用
CN108530522B (zh) * 2018-03-14 2021-09-17 中华人民共和国汕头海关 一种重组的OmpK多表位多肽、构建方法及其应用
CN110467654B (zh) * 2018-05-11 2022-08-09 普莱柯生物工程股份有限公司 口蹄疫病毒样颗粒抗原、其制备的疫苗组合物及其制备方法和应用
CN111233984B (zh) * 2018-11-29 2022-08-12 普莱柯生物工程股份有限公司 一种o型口蹄疫病毒样颗粒抗原、及其疫苗组合物、制备方法和应用
US12226472B2 (en) * 2019-01-15 2025-02-18 Pulike Biological Engineering, Inc. Foot-and-mouth disease virus-like particle antigen, and vaccine composition, preparation method, and application thereof
CN114423779B (zh) * 2019-06-28 2024-07-02 株式会社准绳生命科学 口蹄疫病毒疫苗组合物
US20230390380A1 (en) * 2020-10-22 2023-12-07 Intervet Inc. Baculovirus expression vector
AU2021363609A1 (en) * 2020-10-22 2023-05-11 Intervet International B.V. Baculovirus expression vector
US12453767B2 (en) 2021-08-18 2025-10-28 The United States Of America, As Represented By The Secretary Of Agriculture Development of mosaic vaccines against foot and mouth disease virus serotype O
IL310905A (en) * 2021-08-20 2024-04-01 Intervet Int Bv A method for producing a virus-like particle for foot-and-mouth disease virus
WO2023020738A1 (en) * 2021-08-20 2023-02-23 The Pirbright Institute Fmdv virus-like particle with double stabilizing mutation
WO2023020737A1 (en) * 2021-08-20 2023-02-23 Intervet International B.V. Fmdv virus-like particle with stabilizing mutation
KR20240046569A (ko) * 2021-08-20 2024-04-09 인터벳 인터내셔널 비.브이. 구제역 바이러스 바이러스-유사 입자의 생성 방법
KR102513632B1 (ko) * 2021-11-30 2023-03-28 주식회사 왓슨알앤디 구제역 바이러스 유사 입자를 생산하기 위한 백신 플랫폼
US12036318B2 (en) * 2022-02-16 2024-07-16 Chemical & Schutz High Performance Lubricants, S.A. De C.V. Self-emulsionable mineral oil as a vehicle in vaccines for poultry
JP2025538585A (ja) * 2022-11-23 2025-11-28 オプティファーム カンパニー リミテッド 口蹄疫ウィルス様粒子またはナノ粒子生産のための組換え発現ベクターおよびこれを用いたワクチン組成物
CN120265316A (zh) 2022-11-23 2025-07-04 致优制药有限公司 用于生产口蹄疫病毒样颗粒或纳米颗粒的重组表达载体及利用其的疫苗组合物
CN117210501B (zh) * 2023-09-13 2024-06-07 中国农业科学院兰州兽医研究所 口蹄疫病毒2b蛋白免疫抑制位点突变的重组口蹄疫病毒株的构建
CN117304277B (zh) * 2023-09-26 2024-03-08 中国农业科学院兰州兽医研究所 一种o型口蹄疫病毒vp4蛋白t细胞表位多肽及其应用
US20250134984A1 (en) * 2023-10-26 2025-05-01 The United States Of America, As Represented By The Secretary Of Agriculture Development of mosaic vaccines against foot and mouth disease virus serotype asia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA915593B (en) 1990-07-24 1993-03-31 Novagene Inc Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same
FR2810888B1 (fr) * 2000-06-29 2004-07-30 Merial Sas Vaccin contre la fievre aphteuse
ES2424847T3 (es) * 2004-06-25 2013-10-09 Merial Ltd. Genes del virus de la fiebre aftosa que expresan avipox recombinantes
EP1951297A2 (en) 2005-11-10 2008-08-06 GenVec, Inc. Adenoviral vector-based foot-and-mouth disease vaccine
KR101164602B1 (ko) * 2008-01-09 2012-07-10 주식회사 케이알바이오텍 배큘로바이러스?기반 백신
CN101270155B (zh) * 2008-05-06 2011-04-27 中国农业科学院兰州兽医研究所 通过耐酸性改造在昆虫中组装口蹄疫病毒空衣壳的方法
GB0810710D0 (en) * 2008-06-11 2008-07-16 Animal Health Inst Vaccine
EP2944322B1 (en) 2010-03-12 2018-01-17 Merial, Inc Bluetongue virus recombinant vaccines and uses thereof
ES2651143T3 (es) * 2011-05-13 2018-01-24 Glaxosmithkline Biologicals Sa Antígenos de F de prefusión del VRS
GB201111183D0 (en) * 2011-06-30 2011-08-17 Animal Health Inst Peptide
CA2876762A1 (en) * 2012-06-18 2013-12-27 Novartis Ag Stabilized gp120
US9738689B2 (en) * 2013-03-13 2017-08-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Prefusion RSV F proteins and their use

Also Published As

Publication number Publication date
AP2017009834A0 (en) 2017-03-31
EP3197486A1 (en) 2017-08-02
CN107073100B (zh) 2021-02-26
AU2015320673A1 (en) 2017-05-11
MX2017003712A (es) 2017-06-28
CA2962225A1 (en) 2016-03-31
RU2745373C2 (ru) 2021-03-24
PY1548374A (es) 2018-01-01
AU2015320673B2 (en) 2019-05-02
ZA201701851B (en) 2018-05-30
MX388708B (es) 2025-03-20
TW201625297A (zh) 2016-07-16
MA40151A1 (fr) 2018-01-31
RU2017113571A3 (ar) 2019-04-22
AR102006A1 (es) 2017-01-25
WO2016049209A1 (en) 2016-03-31
US20160220659A1 (en) 2016-08-04
KR20170058430A (ko) 2017-05-26
TWI733653B (zh) 2021-07-21
BR112017005833A8 (pt) 2023-02-14
JP2017530124A (ja) 2017-10-12
JP6931327B2 (ja) 2021-09-01
KR102526219B1 (ko) 2023-04-26
CN107073100A (zh) 2017-08-18
RU2017113571A (ru) 2018-10-26
US10010605B2 (en) 2018-07-03
MA40151B2 (fr) 2022-12-30
AU2019210537A1 (en) 2019-08-15
BR112017005833A2 (pt) 2018-02-27

Similar Documents

Publication Publication Date Title
JO3600B1 (ar) لقاحات مؤتلفة ل fmdv و استخداماتها
NZ602278A (en) Bluetongue virus recombinant vaccines and uses thereof
NZ744786A (en) Recombinant adenovirus vectored fmdv vaccines and uses thereof
MX2017001406A (es) Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva.
DK3570879T3 (da) Immunogene sammensætninger til anvendelse i pneumokokvacciner
IL257800A (en) Immune compositions with improved stability and immunogenicity
DK3244917T5 (da) Immunogene sammensætninger til anvendelse i pneumokokvacciner
DK3096785T3 (da) Immunogene sammensætninger omfattende konjugerede kapsel-saccharid-antigener og anvendelser deraf
NZ743236A (en) Fmdv and e2 fusion proteins and uses thereof
ZA201701000B (en) Attenuated bovine coronavirus and related vaccines
EP3439693A4 (en) NEW PNEUMOCOCCAL VACCINE FORMULATIONS
PT3498850T (pt) Cassete de expressão heteróloga, construção de dna e composição de vacina para imunização contra flavivírus e/ou outros patogénios
EA201690378A1 (ru) Вакцинные композиции против наркотической зависимости
PH12018500372A1 (en) Fcv recombinant vaccines and uses thereof
UY36328A (es) Vacunas de fmdv recombinante y usos de las mismas
EA201691202A1 (ru) Флагеллин-содержащие белковые наночастицы в качестве платформы для вакцины
TH1701007335A (th) วิธีการสำหรับการปรับปรุงการดูดซับของคอนจูเกตโพลีแซคคาไรด์-โปรตีน และ สูตรตำรับมัลติวาเลนท์วัคซีนที่ถูกได้มาจากสิ่งนั้น